BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16135788)

  • 1. The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene.
    Wang L; Baiocchi RA; Pal S; Mosialos G; Caligiuri M; Sif S
    Mol Cell Biol; 2005 Sep; 25(18):7953-65. PubMed ID: 16135788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes.
    Pal S; Vishwanath SN; Erdjument-Bromage H; Tempst P; Sif S
    Mol Cell Biol; 2004 Nov; 24(21):9630-45. PubMed ID: 15485929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of BAF57 mutations in human breast cancer cell lines.
    Kiskinis E; García-Pedrero JM; Villaronga MA; Parker MG; Belandia B
    Breast Cancer Res Treat; 2006 Jul; 98(2):191-8. PubMed ID: 16538531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for BAF57 in cell cycle-dependent transcriptional regulation by the SWI/SNF chromatin remodeling complex.
    Hah N; Kolkman A; Ruhl DD; Pijnappel WW; Heck AJ; Timmers HT; Kraus WL
    Cancer Res; 2010 Jun; 70(11):4402-11. PubMed ID: 20460533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of novel potentially oncogenic mutations in the human BAF57 gene in a breast cancer patient.
    Villaronga MA; López-Mateo I; Markert L; Espinosa E; Fresno Vara JA; Belandia B
    Breast Cancer Res Treat; 2011 Aug; 128(3):891-8. PubMed ID: 21465167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of the INI1 tumor suppressor does not impair the expression of multiple BRG1-dependent genes or the assembly of SWI/SNF enzymes.
    Doan DN; Veal TM; Yan Z; Wang W; Jones SN; Imbalzano AN
    Oncogene; 2004 Apr; 23(19):3462-73. PubMed ID: 14990991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulating SWI/SNF subunit levels via protein-protein interactions and proteasomal degradation: BAF155 and BAF170 limit expression of BAF57.
    Chen J; Archer TK
    Mol Cell Biol; 2005 Oct; 25(20):9016-27. PubMed ID: 16199878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminally truncated BAF57 isoforms contribute to the diversity of SWI/SNF complexes in neurons.
    Kazantseva A; Sepp M; Kazantseva J; Sadam H; Pruunsild P; Timmusk T; Neuman T; Palm K
    J Neurochem; 2009 May; 109(3):807-18. PubMed ID: 19245665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB.
    Betz BL; Strobeck MW; Reisman DN; Knudsen ES; Weissman BE
    Oncogene; 2002 Aug; 21(34):5193-203. PubMed ID: 12149641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies.
    Decristofaro MF; Betz BL; Rorie CJ; Reisman DN; Wang W; Weissman BE
    J Cell Physiol; 2001 Jan; 186(1):136-45. PubMed ID: 11147808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SWI/SNF chromatin remodeling subunit BAF57 is a critical regulator of estrogen receptor function in breast cancer cells.
    García-Pedrero JM; Kiskinis E; Parker MG; Belandia B
    J Biol Chem; 2006 Aug; 281(32):22656-64. PubMed ID: 16769725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function.
    Cheng SW; Davies KP; Yung E; Beltran RJ; Yu J; Kalpana GV
    Nat Genet; 1999 May; 22(1):102-5. PubMed ID: 10319872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant BAF57 signaling facilitates prometastatic phenotypes.
    Balasubramaniam S; Comstock CE; Ertel A; Jeong KW; Stallcup MR; Addya S; McCue PA; Ostrander WF; Augello MA; Knudsen KE
    Clin Cancer Res; 2013 May; 19(10):2657-67. PubMed ID: 23493350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.
    Link KA; Balasubramaniam S; Sharma A; Comstock CE; Godoy-Tundidor S; Powers N; Cao KH; Haelens A; Claessens F; Revelo MP; Knudsen KE
    Cancer Res; 2008 Jun; 68(12):4551-8. PubMed ID: 18559499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitotic inactivation of a human SWI/SNF chromatin remodeling complex.
    Sif S; Stukenberg PT; Kirschner MW; Kingston RE
    Genes Dev; 1998 Sep; 12(18):2842-51. PubMed ID: 9744861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells.
    Vachtenheim J; Ondrusová L; Borovanský J
    Biochem Biophys Res Commun; 2010 Feb; 392(3):454-9. PubMed ID: 20083088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes.
    Sif S; Saurin AJ; Imbalzano AN; Kingston RE
    Genes Dev; 2001 Mar; 15(5):603-18. PubMed ID: 11238380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF.
    Link KA; Burd CJ; Williams E; Marshall T; Rosson G; Henry E; Weissman B; Knudsen KE
    Mol Cell Biol; 2005 Mar; 25(6):2200-15. PubMed ID: 15743818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of BAF57 in ovarian cancer cells and drug sensitivity.
    Yamaguchi T; Kurita T; Nishio K; Tsukada J; Hachisuga T; Morimoto Y; Iwai Y; Izumi H
    Cancer Sci; 2015 Apr; 106(4):359-66. PubMed ID: 25611552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INI1 expression induces cell cycle arrest and markers of senescence in malignant rhabdoid tumor cells.
    Reincke BS; Rosson GB; Oswald BW; Wright CF
    J Cell Physiol; 2003 Mar; 194(3):303-13. PubMed ID: 12548550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.